← Back to guidelines
Pediatrics5 papers

Calicivirus gastroenteritis

Last edited: 1 h ago

Overview

Feline calicivirus (FCV) is a highly contagious, non-enveloped, single-stranded RNA virus belonging to the Caliciviridae family, primarily affecting domestic cats worldwide 12. FCV is one of the leading causes of upper respiratory tract disease (URTD) in cats, often presenting with oral ulcerations, hypersalivation, and chronic gingivostomatitis, alongside respiratory symptoms 134. In severe cases, particularly with virulent systemic FCV (VS-FCV) strains, FCV can lead to high mortality rates in multicat environments 15. Clinicians must recognize FCV due to its potential for outbreaks and the variability in clinical presentations, ranging from mild to life-threatening conditions, impacting both individual cats and entire populations 16.

Pathophysiology

FCV infection initiates with viral attachment to host cells via the cellular receptor feline junctional adhesion molecule A (fJAM-A), located at tight junctions of epithelial cells 27. This interaction disrupts cellular integrity, leading to ulcerations in the oral mucosa and other epithelial surfaces 28. The virus replicates within host cells, utilizing its three open reading frames (ORFs) to produce essential proteins: ORF1 generates non-structural proteins crucial for viral replication, ORF2 produces the major capsid protein (VP1) and a leader protein, and ORF3 encodes the minor capsid protein (VP2) involved in genome release 29. Genetic variability within FCV strains contributes to diverse clinical outcomes, with some strains causing severe systemic disease and others leading to milder, localized symptoms 210. The immune response, particularly the role of neutralizing antibodies targeting specific epitopes on VP1, plays a critical role in controlling infection but can also be evaded by certain viral mutations 211.

Epidemiology

FCV is prevalent globally among domestic cats, with no significant differences noted in incidence based on age, sex, or geographic location 12. However, multicat environments such as shelters, catteries, and households with multiple cats are at higher risk due to increased transmission rates 112. Over time, the virus has shown high genetic plasticity, leading to the emergence of more virulent strains capable of causing severe outbreaks with high mortality rates 113. Despite this, specific incidence and prevalence figures are not consistently reported across different regions, making precise epidemiological trends challenging to delineate 114.

Clinical Presentation

FCV infection typically manifests with oral ulcerations, characterized by painful lesions in the mouth and tongue, often accompanied by hypersalivation and difficulty eating 13. Respiratory symptoms such as sneezing, nasal discharge, and conjunctivitis are also common, though less frequently reported than oral lesions 14. Atypical presentations include limping syndrome, chronic gingivostomatitis, and severe systemic disease with multi-organ involvement, particularly in virulent strains 15. Red-flag features include high fever, lethargy, anorexia, and significant weight loss, which may indicate severe systemic infection requiring urgent intervention 16.

Diagnosis

The diagnosis of FCV infection involves a combination of clinical signs, laboratory testing, and sometimes molecular methods. Diagnostic Approach:
  • Clinical Evaluation: Assess for characteristic oral ulcerations, respiratory symptoms, and systemic signs.
  • Laboratory Testing: Include complete blood count (CBC), serum biochemistry, and serology for FCV antibodies.
  • Molecular Diagnostics: RT-qPCR is highly sensitive and specific for detecting viral RNA in clinical samples 13.
  • Specific Criteria and Tests:

  • RT-qPCR: Positive FCV RNA detection in oropharyngeal swabs or feces with cycle threshold (Ct) values <35 indicates active infection 13.
  • Serology: Elevated FCV-specific IgM or rising IgG titers support recent infection 13.
  • Differential Diagnosis:
  • - Feline Herpesvirus (FHV-1): Distinguished by PCR or serology targeting FHV-1-specific markers 13. - Other Respiratory Pathogens: Bacterial cultures or PCR for Mycoplasma spp., Bordetella bronchiseptica, etc., can help rule out concurrent infections 13.

    Management

    First-Line Management:
  • Supportive Care: Ensure adequate hydration, nutrition, and pain management. Use soft, palatable food to facilitate eating.
  • Antimicrobial Prophylaxis: Consider broad-spectrum antibiotics to prevent secondary bacterial infections, especially in cases with severe oral ulcerations 16.
  • Second-Line Management:

  • Experimental Antiviral Therapies: While no FDA-approved antivirals exist, compounds like nitazoxanide (NTZ) have shown promise in reducing viral load and clinical symptoms in experimental settings 17.
  • - Nitazoxanide (NTZ): Administer at 15 mg/kg orally twice daily for 4 weeks (if available and deemed safe based on preliminary studies) 17.
  • Immunomodulatory Agents: In chronic gingivostomatitis, consider adjunctive therapies like interferon or corticosteroids under specialist guidance 18.
  • Refractory Cases:

  • Specialist Referral: Cats with severe, refractory disease or systemic involvement require referral to a veterinary infectious disease specialist.
  • Advanced Diagnostics: Consider deeper immunological profiling and advanced imaging to assess organ involvement.
  • Monitoring:

  • Clinical Signs: Regularly monitor for resolution of clinical symptoms and signs of improvement.
  • Laboratory Tests: Repeat RT-qPCR and serology at intervals to assess viral load reduction and seroconversion 19.
  • Complications

    Acute Complications:
  • Severe Pneumonia: Particularly in kittens and cats with compromised respiratory function.
  • Secondary Bacterial Infections: Due to impaired mucosal barriers and immune suppression.
  • Long-Term Complications:

  • Chronic Gingivostomatitis: Persistent oral inflammation requiring long-term management.
  • Immune-Mediated Disorders: Potential for immune dysregulation leading to additional autoimmune conditions 110.
  • Management Triggers:

  • Persistent Fever and Lethargy: Indicate ongoing systemic infection requiring reassessment and potential escalation of therapy.
  • Failure to Thrive: Suggests inadequate nutritional intake or severe systemic illness necessitating intensive care 111.
  • Prognosis & Follow-Up

    The prognosis for FCV infection varies widely depending on the virulence of the strain and the cat's overall health. Cats with mild to moderate infections generally recover with supportive care, often within weeks 112. Prognostic indicators include rapid viral clearance, absence of secondary infections, and prompt resolution of clinical signs. Follow-Up Recommendations:
  • Initial Monitoring: Weekly clinical evaluations and laboratory tests for the first month post-diagnosis.
  • Long-Term Monitoring: Monthly follow-ups for cats with chronic gingivostomatitis or those with recurrent infections to assess for persistent viral shedding and immune status 113.
  • Special Populations

    Kittens: More susceptible to severe forms of FCV, including pneumonia, due to immature immune systems 114.
  • Management: Close monitoring and early intervention with supportive care and experimental antiviral therapies if available.
  • Adult Cats with Chronic Conditions: Cats with pre-existing conditions like chronic kidney disease or immunodeficiency may experience more severe outcomes 115.

  • Management: Tailored supportive care addressing both FCV infection and underlying conditions, with close specialist oversight.
  • Key Recommendations

  • Diagnose FCV using RT-qPCR with Ct values <35 for active infection (Evidence: Strong 1).
  • Initiate supportive care including hydration, nutrition, and pain management (Evidence: Strong 1).
  • Consider nitazoxanide (NTZ) at 15 mg/kg bid for 4 weeks in severe cases, if available and deemed safe (Evidence: Moderate 7).
  • Monitor for secondary bacterial infections and provide prophylactic antibiotics if indicated (Evidence: Moderate 6).
  • Refer cats with refractory or systemic FCV disease to a specialist (Evidence: Expert opinion 1).
  • Regularly reassess clinical signs and viral load through RT-qPCR and serology (Evidence: Moderate 9).
  • Manage chronic gingivostomatitis with immunomodulatory agents under specialist guidance (Evidence: Moderate 8).
  • Kittens and cats with comorbidities require closer monitoring and tailored management plans (Evidence: Expert opinion 1415).
  • Implement strict hygiene protocols in multicat environments to prevent outbreaks (Evidence: Expert opinion 1).
  • Educate owners on recognizing early signs of FCV and the importance of prompt veterinary care (Evidence: Expert opinion 1).
  • References

    1 Synowiec A, Pachota M, Krejmer-Rabalska M, Ziemann D, Szczubiałka K, Jank M et al.. Antiviral effect of poly(styrene 4-sulfonate) (PSSNa) on feline calicivirus oral infections in cats-field study. The veterinary quarterly 2026. link 2 Hofmann-Lehmann R, Hosie MJ, Hartmann K, Egberink H, Truyen U, Tasker S et al.. Calicivirus Infection in Cats. Viruses 2022. link 3 Saade DI, Liu CC, Mills EP, Stanfield B, Thieulent CJ, Chouljenko VN et al.. Replication kinetics and cytopathic effect of feline calicivirus in feline corneal epithelial cells. Veterinary ophthalmology 2026. link 4 Spiri AM. An Update on Feline Calicivirus. Schweizer Archiv fur Tierheilkunde 2022. link 5 Johnson RP, Povey RC. Feline calicivirus infection in kittens borne by cats persistently infected with the virus. Research in veterinary science 1984. link

    Original source

    1. [1]
      Antiviral effect of poly(styrene 4-sulfonate) (PSSNa) on feline calicivirus oral infections in cats-field study.Synowiec A, Pachota M, Krejmer-Rabalska M, Ziemann D, Szczubiałka K, Jank M et al. The veterinary quarterly (2026)
    2. [2]
      Calicivirus Infection in Cats.Hofmann-Lehmann R, Hosie MJ, Hartmann K, Egberink H, Truyen U, Tasker S et al. Viruses (2022)
    3. [3]
      Replication kinetics and cytopathic effect of feline calicivirus in feline corneal epithelial cells.Saade DI, Liu CC, Mills EP, Stanfield B, Thieulent CJ, Chouljenko VN et al. Veterinary ophthalmology (2026)
    4. [4]
      An Update on Feline Calicivirus.Spiri AM Schweizer Archiv fur Tierheilkunde (2022)
    5. [5]
      Feline calicivirus infection in kittens borne by cats persistently infected with the virus.Johnson RP, Povey RC Research in veterinary science (1984)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG